Cure Alzheimer’s Fund Receives Federal Funding to Support Promising Research on Genetic Causes, Cure for Disease

Posted December 17, 2009

Washington, December 17, 2009 — President Obama this week signed a bill into law that includes funding to support the Boston-based Cure Alzheimer’s Fund’s efforts to find cure for Alzheimer’s disease.

Submitted as part of the Consolidated Appropriations Act of 2010 by Sens. John Kerry and Paul Kirk, and Rep. Ed Markey, Cure Alzheimer’s Fund was recognized for its work in the field of Alzheimer’s disease research and granted $150,000 in federal funding for state-of-the-art equipment for research.


“We thank Senators Kerry and Kirk, and the late Senator Kennedy and Congressman Markey for their efforts to acknowledge our work to make Alzheimer’s a distant memory,” said Tim Armour, president and CEO of Cure Alzheimer’s Fund. “Our goal is to find a cure within 10 years, and our research programs are the key to discovery. This federal funding shows our government is paying attention and dedicated to fighting this debilitating disease.”


The funding will support the “Alzheimer’s Genome Project” (AGP), part of the ambitious national research strategy set forth by Cure Alzheimer’s Fund to identify the causes and better understand the disease. Time Magazine/CNN saluted AGP as a “Top Ten Medical Breakthrough of 2008.”  Approximately 5.2 million Americans currently battle Alzheimer’s and the clock is ticking as the Baby Boomer generation approaches the at-risk age group.


Cure Alzheimer’s Fund™ is a 501c3 public charity established to fund targeted research with the highest probability of slowing, stopping or reversing Alzheimer’s disease.  For more information, please visit